Page last updated: 2024-08-25

imidazo(1,2-a)pyridine and Leishmaniasis, Visceral

imidazo(1,2-a)pyridine has been researched along with Leishmaniasis, Visceral in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Brand, S; De Rycker, M; Dodd, PG; Fiandor, JM; Gilbert, IH; Ko, EJ; Lukac, I; Manthri, S; Marco, M; Martin, J; McGonagle, K; Miles, TJ; Osuna-Cabello, M; Pont, C; Read, KD; Riley, J; Simeons, F; Stojanovski, L; Thomas, J; Thomas, M; Thompson, S; Viayna, E; Wyatt, PG; Zuccotto, F	1

Other Studies

1 other study(ies) available for imidazo(1,2-a)pyridine and Leishmaniasis, Visceral

Article	Year
Scaffold-Hopping Strategy on a Series of Proteasome Inhibitors Led to a Preclinical Candidate for the Treatment of Visceral Leishmaniasis. Journal of medicinal chemistry, 2021, 05-13, Volume: 64, Issue:9 Topics: Animals; Antiprotozoal Agents; Binding Sites; Cell Line; Drug Design; Drug Evaluation, Preclinical; Half-Life; Humans; Leishmania donovani; Leishmaniasis, Visceral; Mice; Molecular Dynamics Simulation; Proteasome Endopeptidase Complex; Proteasome Inhibitors; Protein Subunits; Protozoan Proteins; Pyridines; Solubility; Structure-Activity Relationship	2021

Article

Year

Scaffold-Hopping Strategy on a Series of Proteasome Inhibitors Led to a Preclinical Candidate for the Treatment of Visceral Leishmaniasis.

Journal of medicinal chemistry, 2021, 05-13, Volume: 64, Issue:9

Topics: Animals; Antiprotozoal Agents; Binding Sites; Cell Line; Drug Design; Drug Evaluation, Preclinical; Half-Life; Humans; Leishmania donovani; Leishmaniasis, Visceral; Mice; Molecular Dynamics Simulation; Proteasome Endopeptidase Complex; Proteasome Inhibitors; Protein Subunits; Protozoan Proteins; Pyridines; Solubility; Structure-Activity Relationship

2021